Loading...
Expanding anaplastic lymphoma kinase therapeutic indication to early stage non-small cell lung cancer
Oncogene-addicted non-small cell lung cancer (NSCLC) patients have been witnessing overwhelming therapeutic improvements, especially in advanced disease management, due to the advent of more potent tyrosine kinase inhibitors (TKIs). However, the concrete chance to cure anaplastic lymphoma kinase (AL...
Saved in:
| Published in: | Transl Lung Cancer Res |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
AME Publishing Company
2019
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6894993/ https://ncbi.nlm.nih.gov/pubmed/31857952 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr.2019.07.07 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|